UBS Group
GNMK

UBS Group’s GenMark Diagnostics, Inc GNMK Stock Holding History

UBS Group’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-100
Closed -$1K – 9618
2014
Q4 		$1K Buy
+100
New +$1.12K ﹤0.01% 9574

UBS Group's GNMK Position: Q2 2021 in Review

UBS Group sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 12,100 shares — an estimated $289K sold.

UBS Group first reported a position in GNMK in Q4 2014 and held it in 26 quarters. The position peaked at $677K in Q2 2020. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

  • UBS Group reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
  • UBS Group sold 12,100 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $289K.
  • UBS Group first reported a position in GenMark Diagnostics, Inc in Q4 2014 and held it in 26 quarters.
  • UBS Group's GenMark Diagnostics, Inc position peaked at $677K in Q2 2020.
  • 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on UBS Group's 13F filing for Q2 2021, filed 13 Aug 2021.